Formation and persistence of DNA adducts of anticancer drug ellipticine in rats

³²P-Post-labelling analysis of DNA adducts formed in the livers of animals treated with safrole, estragole and other naturally-occurring alkenylbenzenes. II. Newborn male B6C3F₁ mice

David H. Phillips, M. Vijayaraj Reddy, Kurt Randerath · Carcinogenesis · 1984 · 224 citations

Pharmacy, Pharmacology, Toxicology +9

³²P-Post-labelling analysis of DNA adducts formed in the livers of animals treated with safrole, estragole and other naturally-occurring alkenylbenzenes. I. Adult female CD-1 mice

Kurt Randerath, Roberta E. Haglund, David H. Phillips et al. · Carcinogenesis · 1984 · 176 citations

Pharmacy, Toxicology, Carcinogenesis +6

³²P-Postlabeling analysis of DNA adducts persisting for up to 42 weeks in the skin, epidermis and dermis of mice treated topically with 7,12-dimethylbenz[a]anthracene

Erika Randerath, Hari P. Agrawal, James Weaver et al. · Carcinogenesis · 1985 · 156 citations

Pharmacy, Dermatology, Toxicology +13

The anticancer agent ellipticine on activation by cytochrome P450 forms covalent DNA adducts☆

Marie Stiborová, Christian A. Bieler, Eva Frei · Biochemical Pharmacology · 2001 · 148 citations

Medicine, Oncology, Pharmacology +12

Topoisomerase II Binds to Ellipticine in the Absence or Presence of DNA.

Stacie J. Froelich-Ammon, Marcia W. Patchan, Neil Osheroff et al. · Journal of Biological Chemistry · 1995 · 139 citations · Full text

Medicine, Biochemistry, Pharmacology +15